Clinical Trial Update: Characterizing the Host Response to Leptospirosis for Better Diagnosis and Prognosis - NIHFI [NA]

View source ↗

Summary

NIH-funded study led by Institut Pasteur to characterize the host immune response to leptospirosis to improve diagnosis and prognosis; the study is not yet recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leptospirosis

Snippet

Sponsor: Institut Pasteur | Conditions: Leptospirosis | NA | Status: NOT_YET_RECRUITING